# Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

> **NCT02211638** · — · COMPLETED · sponsor: **Takeda** · enrollment: 18113 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan Cilexetil

## Key facts

- **NCT ID:** NCT02211638
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-13
- **Primary completion:** 2013-04-25
- **Final completion:** 2013-04-25
- **Target enrollment:** 18113 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211638, "Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02211638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*